Revealed: The secret investment lesson from 'The Richest Man in Babylon'

Much can go wrong when companies like Harvey Norman Holdings Limited (ASX:HVN), Capitol Health Ltd (ASX:CAJ), and TFS Corporation Limited (ASX:TFC) go outside their circle of competence.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I recently read a book titled 'The Richest Man in Babylon'. More about general investing than stock selection, it's set in ancient Babylon and is an easy read and full of useful parables for modern savers and investors.  One story stuck with me.

I paraphrase, but a rich man in Babylon teaches a poor man first how to save money, and then to invest it and make it grow. The poor man tells his teacher proudly that he gave his savings to Azmur the brick-maker who was travelling to Phoenicia. The brick-maker would buy rare jewels while he was there and they would sell them and split the proceeds on his return.

Can you guess where this story is going?

The teacher replies 'you're an idiot. What does a brick-maker know of rare jewels? Would you ask a baker to explain the movements of the heavens?' Sure enough, the wily Phoenicians tricked Azmur and sold him bits of worthless coloured glass instead of jewels.

A lesson for ASX investors

It's often said that there's nothing new under the sun in investing, and you might be surprised to know how often modern managers of multi-million dollar companies step outside their area of expertise.

Capitol Health Ltd (ASX: CAJ) may have done it when it partnered with Enlitic to deliver machine-learning diagnostics for its scans. As diagnosticians, Capitol Health is likely in a better place to identify coming trends/needs in the sector, and Enlitic's technology certainly appears useful.

However – and I'm not beating up on management here – it's a different question as to whether management has the skills to determine that a US$10 million investment in an unprofitable start-up is likely to reap benefits for shareholders in time. The entirety of Capitol Health is only valued at A$83 million today and the company is under some financial stress, so the investment was significant.

Other more egregious examples include Harvey Norman Holdings Limited's (ASX: HVN) acquisition of a dairy farm, which appeared to be a bid to profit from Australia's booming dairy industry, but understandably sent shares down more than 10% at the time. Investors were no doubt wondering, 'what does this electronics retailer know about dairy farming or agricultural property?'

Another time, TFS Corporation Limited (ASX: TFC) decided to diversify from running sandalwood plantations into developing pharmaceutical therapies from said sandalwood. Whatever the eventual outcome, the venture is extremely expensive and outcomes from any kind of clinical trial are uncertain.

One of the best known examples will be Woolworths Limited (ASX: WOW) and its Masters Hardware venture. Despite the apparent similarities between a hardware warehouse and a grocery shop, and competitor Wesfarmers Ltd's (ASX: WES) (who also owns Coles) success with Bunnings, Woolies' management just couldn't make it work. It cost shareholders a stack of money that they won't get back.

What does this brick-maker know of rare jewels? 

The risks increase when the money diverted to the grand new idea increases. If Masters or pharmaceutical sandalwood research only cost $5 million bucks, it wouldn't be a huge issue. When management is talking about expensive diversification into unrelated businesses, it's important for all investors to ask 'what does the brick maker know of rare jewels?'

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »